Shutting Down a ‘Dark Kinase’ May Defeat Treatment-Resistant Cancers
Slotkin Awarded SOT 2025 Distinguished Neurotoxicologist Award
Abbie Ireland Receives the Dean’s Award for Research Excellence
Discovery of Cancer Cell ‘Factories’ Provides Clues to New Treatments
- Shutting Down a ‘Dark Kinase’ May Defeat Treatment-Resistant Cancers
- Slotkin Awarded SOT 2025 Distinguished Neurotoxicologist Award
- Abbie Ireland Receives the Dean’s Award for Research Excellence
- Discovery of Cancer Cell ‘Factories’ Provides Clues to New Treatments
Upcoming Seminars
April 2
RNHD | Zervantonakis: Tumor-macrophage interactions in 3D microenvironments
12:00 pm to 1:00 pm
April 9
RNHD | Welm: Modeling metastatic breast cancer to advance therapeutic strategies
12:00 pm to 1:00 pm
April 16
RNHD | Nuñez: Rewriting the human epigenome with CRISPR
12:00 pm to 1:00 pm
April 23
RNHD | Chan: Exploiting dysregulated ribosome homeostasis for cancer therapy
12:00 pm to 1:00 pm
Invest in Our Future
At Duke University School of Medicine, donors play a vital role in fostering innovation, enhancing patient care, and training the next generation of health care leaders. Your contributions not only sustain and elevate existing programs but also pave the way for groundbreaking discoveries.